ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Phase I/II tolerability/pharmacokinetic study with one-hour intravenous infusion of doxifluiridine (5?-dFUrd) 3 g/m2 VS 5 g/m2 QD x 5 per month
Cancer Chemotherapy and Pharmacology
◽
10.1007/bf00273397
◽
1986
◽
Vol 18
(3)
◽
Cited By ~ 6
Author(s):
SophieD. Foss�
◽
Asbj�rn Flokkmann
◽
Mona Heier
◽
Magne Aas
◽
Brit Moe
◽
...
Keyword(s):
Phase I
◽
Pharmacokinetic Study
◽
Intravenous Infusion
Download Full-text
Related Documents
Cited By
References
Phase I and Pharmacokinetic Study of Paclitaxel by 24-Hour Intravenous Infusion
Japanese Journal of Cancer Research
◽
10.1111/j.1349-7006.1994.tb02906.x
◽
1994
◽
Vol 85
(10)
◽
pp. 1057-1062
◽
Cited By ~ 14
Author(s):
Tomohide Tamura
◽
Yasutsuna Sasaki
◽
Kenji Eguchi
◽
Tetsu Shinkai
◽
Yuichiro Ohe
◽
...
Keyword(s):
Phase I
◽
Pharmacokinetic Study
◽
Intravenous Infusion
Download Full-text
Phase I and pharmacokinetic study of the topoisomerase I inhibitor, exatecan mesylate (DX-8951f ), using a weekly 30-minute intravenous infusion, in patients with advanced solid malignancies
Annals of Oncology
◽
10.1093/annonc/mdg243
◽
2003
◽
Vol 14
(6)
◽
pp. 913-921
◽
Cited By ~ 8
Author(s):
J.P. Braybrooke
◽
E. Boven
◽
N.P. Bates
◽
R. Ruijter
◽
N. Dobbs
◽
...
Keyword(s):
Phase I
◽
Pharmacokinetic Study
◽
Intravenous Infusion
◽
Topoisomerase I
◽
Topoisomerase I Inhibitor
◽
Solid Malignancies
◽
Exatecan Mesylate
Download Full-text
A phase I pharmacokinetic study of PM00104 (Zalypsis®) administered as a 24-h intravenous infusion every 3 weeks in patients with advanced solid tumors
Cancer Chemotherapy and Pharmacology
◽
10.1007/s00280-013-2119-8
◽
2013
◽
Vol 71
(5)
◽
pp. 1247-1254
◽
Cited By ~ 7
Author(s):
J. Capdevila
◽
S. Clive
◽
E. Casado
◽
C. Michie
◽
A. Piera
◽
...
Keyword(s):
Phase I
◽
Solid Tumors
◽
Pharmacokinetic Study
◽
Intravenous Infusion
◽
Advanced Solid Tumors
Download Full-text
A phase I clinical and pharmacokinetic study of the dolastatin analogue cemadotin administered as a 5-day continuous intravenous infusion
Cancer Chemotherapy and Pharmacology
◽
10.1007/s002800000152
◽
2000
◽
Vol 46
(4)
◽
pp. 319-328
◽
Cited By ~ 21
Author(s):
Jeffrey G. Supko
◽
Thomas J. Lynch
◽
Jeffrey W. Clark
◽
Robert Fram
◽
Lee F. Allen
◽
...
Keyword(s):
Phase I
◽
Pharmacokinetic Study
◽
Intravenous Infusion
◽
Continuous Intravenous Infusion
Download Full-text
Recombinant human endostatin administered as a 28-day continuous intravenous infusion, followed by daily subcutaneous injections: a phase I and pharmacokinetic study in patients with advanced cancer
Annals of Oncology
◽
10.1093/annonc/mdi318
◽
2005
◽
Vol 16
(10)
◽
pp. 1695-1701
◽
Cited By ~ 45
Author(s):
A.H.G. Hansma
◽
H.J. Broxterman
◽
I. van der Horst
◽
Y. Yuana
◽
E. Boven
◽
...
Keyword(s):
Phase I
◽
Advanced Cancer
◽
Pharmacokinetic Study
◽
Intravenous Infusion
◽
Continuous Intravenous Infusion
◽
Recombinant Human Endostatin
◽
Subcutaneous Injections
Download Full-text
Phase I clinical and pharmacokinetic study of cyclophosphamide administered by five-day continuous intravenous infusion
Cancer Chemotherapy and Pharmacology
◽
10.1007/bf00253060
◽
1986
◽
Vol 18
(1)
◽
pp. 33-38
◽
Cited By ~ 10
Author(s):
N. Simon Tchekmedyian
◽
Merrill J. Egorin
◽
Brian E. Cohen
◽
Richard S. Kaplan
◽
Elizabeth Poplin
◽
...
Keyword(s):
Phase I
◽
Pharmacokinetic Study
◽
Intravenous Infusion
◽
Continuous Intravenous Infusion
Download Full-text
Phase I and pharmacokinetic study of TZT-1027, a novel synthetic dolastatin 10 derivative, administered as a 1-hour intravenous infusion every 3 weeks in patients with advanced refractory cancer
Annals of Oncology
◽
10.1093/annonc/mdh141
◽
2004
◽
Vol 15
(4)
◽
pp. 671-679
◽
Cited By ~ 41
Author(s):
P. Schöffski
◽
B. Thate
◽
G. Beutel
◽
O. Bolte
◽
D. Otto
◽
...
Keyword(s):
Phase I
◽
Pharmacokinetic Study
◽
Intravenous Infusion
◽
Dolastatin 10
Download Full-text
Phase I Clinical and Pharmacokinetic Study of Plitidepsin as a 1-Hour Weekly Intravenous Infusion in Patients with Advanced Solid Tumors
Clinical Cancer Research
◽
10.1158/1078-0432.ccr-07-1652
◽
2008
◽
Vol 14
(10)
◽
pp. 3105-3112
◽
Cited By ~ 24
Author(s):
Miguel A. Izquierdo
◽
Angela Bowman
◽
Margarita García
◽
Duncan Jodrell
◽
Marisa Martinez
◽
...
Keyword(s):
Phase I
◽
Solid Tumors
◽
Pharmacokinetic Study
◽
Intravenous Infusion
◽
Advanced Solid Tumors
Download Full-text
Phase I and pharmacokinetic study of paclitaxel by a 3-hour intravenous infusion
Lung Cancer
◽
10.1016/0169-5002(94)94126-2
◽
1994
◽
Vol 11
◽
pp. 93
Keyword(s):
Phase I
◽
Pharmacokinetic Study
◽
Intravenous Infusion
Download Full-text
A multicentre phase I and pharmacokinetic study of BN80915 (diflomotecan) administered daily as a 20-min intravenous infusion for 5 days every 3 weeks to patients with advanced solid tumours
Annals of Oncology
◽
10.1093/annonc/mdl439
◽
2007
◽
Vol 18
(3)
◽
pp. 569-575
◽
Cited By ~ 15
Author(s):
L. Scott
◽
O. Soepenberg
◽
J. Verweij
◽
M.J.A. de Jonge
◽
A.S. Th Planting
◽
...
Keyword(s):
Phase I
◽
Pharmacokinetic Study
◽
Intravenous Infusion
◽
Solid Tumours
◽
Multicentre Phase
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close